Skip to main content
Fig. 5 | Journal of Experimental & Clinical Cancer Research

Fig. 5

From: (Arg)9-SH2 superbinder: a novel promising anticancer therapy to melanoma by blocking phosphotyrosine signaling

Fig. 5

(Arg)9-GST SH2 TrM repressed migration of melanoma cells. a Wound healing assays were monitored at 0 h and 16 h for B16F10, A375 and A375/DDP cells treated with (Arg)9-GST SH2 TrM or (Arg)9-GST. Scale bar: 100 μm. b Transwell migration assays of B16F10, A375 and A375/DDP cells treated with (Arg)9-GST SH2 TrM or (Arg)9-GST at 1 μM for 16 h (n = 3, *P < 0.05). Scale bar: 20 μm. All images shown are representative of at least three independent experiments

Back to article page